Markets
Stocks
Mutual Funds & ETF's
Sectors
Rates
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Merck & Co., Inc. (NY: MRK)
46.80 USD  -0.53 (-1.13%)
Streaming Delayed Price  /  Updated: 11:27 AM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Merck & Co., Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
AtheroNova Mentioned by Analyst in Life Sciences Report
Today 12:15 EDT
from ACCESSWIRE
Secrets to Making Money in CLWR, MS, MRK and KWK
Today 10:00 EDT
from Marketwired News Releases
Approaching Resistance: Merck
May 23, 2013
New York, May 23rd (TradersHuddle.com) - Shares of Merck & Co. Inc. ( NYSE:MRK ) are trading very close to calculated resistance at $48.30. The stock ended the trading session at just $47.33, which is... Read More
from TradersHuddle.com
UPDATE 2-Boy Scouts of America votes to end century-old ban on gay scouts
May 23, 2013
GRAPEVINE, Texas, May 23 (Reuters) - The Boy Scouts of America voted on Thursday to lift a century-old ban on openly gay scouts in a major victory for gay rights activists, but the decision means a sea... Read More
category companyNews
from Reuters: Company News
Merck halts development of experimental Parkinson's drug
May 23, 2013
May 23 (Reuters) - Merck & Co has ended development of preladenant, an experimental drug for Parkinson's disease, after initial data from three late-stage trials proved disappointing. Read More
category companyNews
from Reuters: Company News
Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will Discontinue
May 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8367015 for the full story. Read More
from StreetInsider.com News Articles
Merck Issues Update on Phase III Trial for Preladenant
May 23, 2013
Merck (NYSE: MRK ), known as MSD outside the United States and Canada, today provided an update on the clinical program for preladenant, Merck's investigational adenosine A2[A ]receptor antagonist for... Read More
category Benzinga , News , MRK , and 1 more.
from Latest Articles from Benzinga.com
Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine
May 23, 2013
from Business Wire News Releases
Hot Movers on Health & Fitness Sector : ELN, MRK, JNJ, GILD
May 23, 2013
New York, NY -- (SBWIRE) -- 05/23/2013 -- The online Stock Consultant latest screen has found a biotech company that develops drugs for Alzheimer's and Parkinson's diseases Elan Corporation, PLC (ADR)... Read More
from SBWire - Latest Press Releases
Corporate Stock Buybacks Driving Today's Action?
May 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8366114 for the full story. Read More
from StreetInsider.com News Articles
Inside Merck's new crusade against cervical cancer in Africa
May 23, 2013
Most pharmaceutical companies spend huge money on research and development, with new drugs requiring years of testing before U... Read More
category Health Care , Bill and Melinda Gates Foundation , U/S/ Food and Drug Administration , and 4 more.
from Business Journals
Save A Small Fortune By Forming Your Own Retirement Village
May 23, 2013
There is no place like home for Victor King McElheny, a visiting scholar at MIT's School of Humanities, Arts and Sciences, and former director of the M.I.T Science Writing Program. At 70 years of age,... Read More
category NYSE:JNJ , NYSE:MRK , NYSE:ABT , and 2 more.
from Forbes Real Time
New Stock Coverage: Can Johnson &amp; Johnson Be Market's Band-Aid?
May 23, 2013
Wall Street ratings agencies set the tone for today's stock market. Read More
category JNJ , MRK
from Minyanville Headlines
Why Dow Jones Laggards Are Important Leading Indicators
May 23, 2013
category Iron & Steel , Pharmaceuticals , IT Services & Computers , and 1 more.
from Trefis
Free Research Reports on GILD, MRK, ONCY and PFE Issued by the Bedford Report
May 23, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Early Movers: HRL, HPQ, TSLA, JCP & More
May 23, 2013
These are the stocks posting the largest moves before the bell. Read More
category Tesla Motors , Economics , tvcodes/tvearn , and 18 more.
from CNBC.com News
Don't Miss Gains in C, MRK, NTAP and NOK
May 23, 2013
from Marketwired News Releases
Pfizer takes its shot at a vaccine for evasive superbug
May 23, 2013
Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year... Read More
from FOX News
UPDATE 2-Merck's insomnia drug moves a step closer to U.S. approval
May 22, 2013
* FDA panel says suvorexant safe, effective at lower doses Read More
category companyNews
from Reuters: Company News
Merck Issues Statement on FDA Advisory Committee Meeting Results for Suvorexant
May 22, 2013
Merck (NYSE: MRK ), known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee... Read More
category Management , Benzinga , Guidance , and 3 more.
from Latest Articles from Benzinga.com
UPDATE 1-FDA panel says Merck's sleep drug safe, effective at lower dose
May 22, 2013
WASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug was safe and effective at the lower of two doses studied, a panel of medical experts said on Wednesday, increasing the chance it... Read More
category companyNews
from Reuters: Company News
Merck Statement on FDA Advisory Committee Meeting for Suvorexant
May 22, 2013
from Business Wire News Releases
FDA panel: Merck's insomnia drug effective, safe at low doses
May 22, 2013
WASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts said on Wednesday. Read More
category companyNews
from Reuters: Company News
Merck's (MRK) Suvorexant Helps People Sleep, Says FDA
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8362620 for the full story. Read More
from StreetInsider.com News Articles
Don’t Follow Me, I’m Lost: Stock Buybacks
May 22, 2013
category BRK/B , HD , MRK , and 3 more.
from YCharts
All Penny Stocks.com News: Aradigm Corp Shares Rise on Exclusive License Deal with Grifols
May 22, 2013
Mississauga, ON -- (SBWIRE) -- 05/22/2013 -- AllPennyStocks.com Media, Inc. (AllPennyStocks.com/) announces its latest article titled “Aradigm Corp Shares Rise on Exclusive License Deal with Grifols.” Read More
from SBWire - Latest Press Releases
StreetInsider.com Pre-Open Movers 5/22: (ZLC) (SKS) (TOL) Higher; (UAN) (TGT) (SODA) Lower (more...)
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8361494 for the full story. Read More
from StreetInsider.com News Articles
Stocks Open Higher Ahead of Bernanke Testimony
May 22, 2013
Stocks opened higher on Wednesday as markets await Congressional testimony from Federal Reserve chief Ben Bernanke on the economy and monetary policy at 10:00 a.m. for any clues as to when the central... Read More
category Economics , Merck & Co Inc , Boeing Co , and 13 more.
from CNBC.com News
Critical Alerts For HSBC, Merck, CSX, Wynn Resorts, and Lam Research Released By InvestorsObserver
May 22, 2013
from PR Newswire
PreMarket Info Recap for May 22, 2013
May 22, 2013
Have you ever woken up to find that a stock in your portfolio made a dramatic move overnight? Are you interested in learning how to understand each day's post-market and pre-market moves? Veteran... Read More
category Benzinga , Movers , News , and 14 more.
from Latest Articles from Benzinga.com
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here